Cyclin H 抗体
Quick Overview for Cyclin H 抗体 (ABIN6736919)
抗原
See all Cyclin H (CCNH) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            特异性
- Recognizes human Cyclin H.
- 
                                            纯化方法
- Protein G purified
- 
                                            免疫原
- 
                        Recombinant human Cyclin H.
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG2a
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Approved: WB
 Usage: Suitable for use in Dot Blot and Western Blot.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, 1 % BSA, 0.05 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - Cyclin H (CCNH)
- 
                                            别名
- CCNH / Cyclin H
- 
                                            背景
- 
                        Name/Gene ID: CCNH
 Synonyms: CCNH, Cyclin H, p34, p37, CAK, CAK complex subunit, Cyclin-H, MO15-associated protein
- 
                                            基因ID
- 902
- 
                                            UniProt
- P51946
- 
                                            途径
- Cell Division Cycle, Mitotic G1-G1/S Phases, M Phase
 抗原
- 
                    
 
                                     
                                     
                                    